Xcout Intel
Quoin Pharmaceuticals, Ltd. competitors & alternatives
The 12 closest competitors and alternatives to Quoin Pharmaceuticals, Ltd. among pharmaceuticals companies — ranked by similarity to what Quoin Pharmaceuticals, Ltd. actually does, not by market-cap band.
Subscribe to see Quoin Pharmaceuticals, Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases.
Quoin Pharmaceuticals, Ltd. at a glance
Quoin Pharmaceuticals, Ltd. is a pharmaceuticals company headquartered in Ashburn, United States. It is publicly listed (QNRX) with a market capitalisation of $13.6M. Xcout tracks 24 named people at Quoin Pharmaceuticals, Ltd., including Dr. Michael Myers (Chief Executive Officer).
Quoin Pharmaceuticals, Ltd. leadership
- Dr. Michael MyersChief Executive Officer
- Sally LawlorChief Financial Officer
- Michael MyersCo-Founder, Chief Executive Officer & Chairman
- Denise CarterCo-Founder, Chief Operating Officer & Director
- Denise Bridget CarterExecutive Officer
- Denise CarterExecutive Officer
18 more named people on record for Quoin Pharmaceuticals, Ltd., with roles, board committees and tenure — see the full roster →
Top 12 Quoin Pharmaceuticals, Ltd. competitors
Ranked by semantic similarity — how close each company is to Quoin Pharmaceuticals, Ltd. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Auven Therapeutics is a privately held specialty pharmaceutical company focused on acquiring, developing, and commercializing late-stage and specialty medicines. It serves patients and healthcare providers through pharmaceutical products developed with industry and clinical partners.
Similar pharmaceuticals company
Egetis Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of treatments for serious, rare diseases with high unmet medical needs. Operating internationally, the public company has its headquarters in Stockholm, Sweden, alongside a growing presence in the United States. Its clinical pipeline targets specialized therapeutic indications to improve patient outcomes.
Similar pharmaceuticals company
Deciphera Pharmaceuticals, LLC is a commercial-stage biopharmaceutical company dedicated to delivering transformational medicines, such as QINLOCK, to patients for the treatment of cancer and rare diseases.
Similar pharmaceuticals company
SFJ Pharmaceuticals is a privately held pharmaceutical development and investment company that helps advance drug candidates through clinical development and regulatory approval. It serves biotechnology and pharmaceutical partners by providing development funding, operational expertise, and global clinical-trial support.
Similar pharmaceuticals company
Hyloris is a specialty biopharma company committed to addressing unmet medical needs through the development of pharmaceutical products and drug delivery solutions. It serves patients and healthcare providers by bringing innovative therapeutic options to the market.
Similar pharmaceuticals company
Azurity Pharmaceuticals is a U.S.-based specialty pharmaceutical company that develops and commercializes medicines for underserved patient populations, including treatments for rare diseases and complex conditions. It focuses on patient-friendly dosage forms and serves healthcare providers, patients, and caregivers, including pediatric and other populations with unmet medication needs.
Similar pharmaceuticals company
SCOHIA PHARMA, Inc. is a clinical-stage specialty bioventure headquartered in Fujisawa, Japan. Established in 2017, the company focuses its research and development on lifestyle-related diseases including cardiovascular, metabolic, and renal disorders.
Similar pharmaceuticals company
Boston Pharmaceuticals is a U.S.-based clinical-stage biopharmaceutical company that acquires, develops, and advances drug candidates for serious diseases. It works with pharmaceutical and biotechnology partners to bring clinical-stage medicines toward commercialization and serves patients with significant unmet medical needs.
Similar pharmaceuticals company
Purpose Pharma International AB is a European pharmaceutical company headquartered in Stockholm, Sweden. The firm is dedicated to giving people with rare diseases a better quality of life.
Biotechnology & Pharmaceuticals
ResQ Pharma, Inc. is a specialty pharmaceutical company founded in 2015 and headquartered in Glenview, Illinois, focused on providing reliable access to life-saving lipid-based therapies such as LipidRescue.
Similar pharmaceuticals company
Pharma Two B Ltd. is a late-clinical stage biopharmaceutical company headquartered in Kiryat Ono, Israel. The company focuses on developing pharmaceutical treatments and therapeutic products for neurological and related medical conditions. It has pursued corporate growth initiatives, including planned public market transactions via mergers.
Pharma
Dicot Pharma is a pharmaceutical company that develops new potency drugs targeting sexual dysfunctions in men. Its primary drug candidate, LIB-01, is designed to treat erectile dysfunction with a prolonged duration of action. The company serves patients and healthcare markets by focusing on next-generation treatments to improve quality of life.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Quoin Pharmaceuticals, Ltd. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Quoin Pharmaceuticals, Ltd.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →